药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Quazepam
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Magaldrate
Magaldrate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Penimepicycline
Penimepicycline can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Tetraferric tricitrate decahydrate.
Quazepam
Dimercaprol
Dimercaprol may increase the nephrotoxic activities of Tetraferric tricitrate decahydrate.
Quazepam
Pipemidic acid
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Rufloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Oxolinic acid
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Sitafloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Prulifloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Pazufloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Difloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Sarafloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Orbifloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.